Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma

A 64-year-old woman developed acute Reiter's syndrome 4 weeks after the start of intravesical Bacillus Calmette-Guérin immunotherapy for a recurrent superficial bladder carcinoma. The absence of any other cause suggests that the bacillus played an etiopathogenic role in this HLA-B27-positive pa...

Full description

Saved in:
Bibliographic Details
Published in:British journal of rheumatology 1993-12, Vol.32 (12), p.1096-1098
Main Authors: Pancaldi, P, Van Linthoudt, D, Alborino, D, Haefliger, J M, Ott, H
Format: Article
Language:English
Subjects:
Arthritis, Reactive - etiology
BCG Vaccine - administration & dosage
BCG Vaccine - adverse effects
BCG Vaccine - therapeutic use
Carcinoma - therapy
Female
Humans
Injections
Middle Aged
Urinary Bladder
Urinary Bladder Neoplasms - therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 64-year-old woman developed acute Reiter's syndrome 4 weeks after the start of intravesical Bacillus Calmette-Guérin immunotherapy for a recurrent superficial bladder carcinoma. The absence of any other cause suggests that the bacillus played an etiopathogenic role in this HLA-B27-positive patient.
ISSN:0263-7103